top of page


Brand Name :


Dosage form :

ophthalmic solution

Indication :

brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% is an alpha-ad-
renergic receptor agonist with a beta-adrenergic receptor inhibitor indicated for the reduction of elevated intraocular
pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due
to inadequately controlled IOP; the IOP-lowering of COMBIGAN® dosed twice a day was slightly less than that seen
with the concomitant administration of 0.5% timolol maleate ophthalmic solution dosed twice a day and 0.2% brimoni-
dine tartrate ophthalmic solution dosed three times per day.

Dosage :

The recommended dose is one drop of COMBIGAN® in the affected eye(s)
twice daily approximately 12 hours apart.

Warning / precaution :

Adverse reactions :

Therapeutic class :

Medication safety issues :

bottom of page